This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Brettschneider, J Articles by Tumani, H Search for Related Content PubMed PubMed Citation Articles by Brettschneider, J Articles by Tumani, H Pubmed/NCBI databases Medline Plus Health Information Multiple Sclerosis Social Bookmarking                         What's this?

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany

A Petzold

Department of Neuroinflammation, Institute of Neurology, Queen Square, London, WC1N 3BG, UK

A Junker

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany

H Tumani

Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany, hayrettin.tumani{at}medizin.uni-ulm.de

Clinically isolated syndrome (CIS) represents the earliest phase of multiple sclerosis (MS). This study tested whether biomarkers for axonal degeneration can improve upon sensitivity and specificity of magnetic resonance imaging (MRI) parameters in predicting conversion from CIS to MS. Patients with CIS (n=52), relapsing-remitting MS (RRMS, n=38) and age-matched controls (n=25) were included. Cerebrospinal fluid (CSF) levels of tau and neurofilaments (NfH^SMI35) were measured using ELISA. The MRI T2-lesion load and the Expanded Disability Status Scale (EDSS) were recorded. CSF tau and NfH^SMI35 were elevated in CIS compared to controls (p<0.05). RRMS patients with acute relapse had higher NfH^SMI35 levels than stable patients. Tau and NfH^SMI35 levels correlated with EDSS in CIS and RRMS. In RRMS, the number of T2-lesions correlated with tau levels (R=0.53, P=0.01). The sensitivity predicting the conversion from CIS to MS was higher for the combination of CSF markers (either tau or NfH^SMI35 elevated) than for MRI (40 versus 34%), but could be further increased to 60% if CSF and MRI criteria were combined. Similarly, the combination of tau and NfH^SMI35 showed higher specificity (94%) than MRI (82%). Tau and NfHSMI35 are valuable biomarkers for axonal damage in the CIS patients. Predicting conversion from CIS to MS can be improved if CSF markers are combined with MRI.

Key Words: axonal damage • cerebrospinal fluid • clinically isolated syndrome • multiple sclerosis • neurofilaments • tau protein

Multiple Sclerosis, Vol. 12, No. 2, 143-148 (2006)
DOI: 10.1191/135248506ms1263oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. E. Teunissen, E. Iacobaeus, M. Khademi, L. Brundin, N. Norgren, M.J.A. Koel-Simmelink, M. Schepens, F. Bouwman, H. A.M. Twaalfhoven, H. J. Blom, et al. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis Neurology, April 14, 2009; 72(15): 1322 - 1329. [Abstract] [Full Text] [PDF]

				K. Rejdak, A. Petzold, Z. Stelmasiak, and G. Giovannoni Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 59 - 66. [Abstract] [PDF]